Medical device licence · 102039 · Class 3
COBAS LIAT SYSTEM
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed November 15, 2018; ended October 21, 2021. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 102039
- Licence holder
- Roche Molecular Systems, IncBranchburg, NJ, United States
- Risk class
- Class III (moderate to high risk)
- Licence type
- System
- First licensed
- November 15, 2018
- Ended
- October 21, 2021
- Devices covered
- 7
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- COBAS CDIFF NUCLEIC ACID TEST FOR USE ON THE COBAS LIAT SYSTEM
- COBAS CDIFF POSITIVE AND NEGATIVE CONTROL KIT FOR USE ON THE COBAS LIAT SYSTEM
- COBAS LIAT ANALYZER
- COBAS LIAT CDIFF SCRIPT
- COBAS LIAT SOFTWARE V 3.1 UPDATE KEY
- COBAS LIAT SOFTWARE V 3.1.1 UPDATE KEY
- COBAS LIAT SOFTWARE V 3.2 UPDATE KEY
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.